Analysis of the effectiveness and safety of maintenance treatment with intravenous ustekinumab in inflammatory bowel disease

Ustekinumab is a monoclonal antibody approved for the treatment of moderate to severe Crohn's disease (CD) and ulcerative colitis (UC). In spite of being an effective treatment, patients may have suboptimal response, or lose it over time. In these cases, ustekinumab intravenous (IV) maintenance...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Revista española de enfermedades digestivas 2024-12
Hauptverfasser:	Pampín Sánchez, Rubén, Gonzalo González, Alba, Fuertes Camporro, Santiago, Goenaga Ansola, Ane, Fórneas Sangil, Andrea, Tembrás Martínez, Sonia, Varela Trastoy, Pilar, Martínez-Múgica Barbosa, Cristina
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!